Surgeon in Ophthalmology, Massachusetts Eye and Ear Infirmary,

Assistant Clinical Professor, Harvard Medical School

Medical Director Associate Eye Physicians and Surgeons, Inc

New Therapeutic Approaches

Dr. Borodic was the first physician and ophthalmologist in the Northeastern United States to use botulinum toxin as a treatment modality.  Botulinum toxin is now known as Botox, Dysport, Myobloc and Xeomin.  He has historically published and pioneered advancements on issues regarding administration technique, application dosing, safety issues, pharmaceutical design, chemical composition and production relative to clinical practice, and discovery on key new applications.  This has led to many publications and patents in both past and present. 

Patents and Publications Links:
Hemifacial Spasm Evaluation and Management Emphasis on Botox Therapy
Myo-osseous Fixation Procedure
Orbicularis Oculi Myo-Osseous Fixation
Use of Fillers as Adjunct Therapy for the Treatment of Lower Face Hemifacial Spasm
High Potency Patent

The use of botulinum toxin for regional movement disorders of the face as well as the rest of the body has blossomed over the last two decades.  Many articles have cited Dr. Borodic’s work in the basic science and clinical practice in these new areas inclusive of cosmetic application, cerebral palsy, spasmodic torticollis, spasticity related to stroke and other forms of adult spasticity, and use in human headache disorders.  (Link to Dr Borodic contributions to general neurologic use of BOTOX)

 

Gary E. Borodic. MD

P: 617.770.0011
F: 617.770.0030 

Quincy Office

1261 Furnace Brook Pkwy
Suite 15
Quincy, MA 02169

Waltham Office

1440 Main St. 
Suite 201

Waltham, MA 02451